Carla Lisette Apeña-Cabrera

Carla Lisette Apeña-Cabrera

Auto-generated profile, based on publicly available information

Carla Lisette Apeña-Cabrera

Instituto Nacional de Salud del Niño-Breña, Lima, Perú

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2023 in Revista Peruana de Medicina Experimental Y Salud Pública
Verified
Journal Article
Open access
PDF file
LCLisbeth Varenia Carrasco-Oros
Lisbeth Varenia Carrasco-Oros
NANoé Atamari-Anahui
Noé Atamari-Anahui
AGAlcida Goñi-Fano
Alcida Goñi-Fano
CSClaudia Sosa-Carmelo
Claudia Sosa-Carmelo
EGEduardo Jesús Guzmán-Quispe
Eduardo Jesús Guzmán-Quispe
CACarla Lisette Apeña-Cabrera
Carla Lisette Apeña-Cabrera
This study aimed to describe the clinical-epidemiological, laboratory, treatment, and follow-up characteristics of patients with hemolytic uremic syndrome (HUS). The medical records of patients with HUS hospitalized at the Instituto Nacional de Salud del Niño-Breña (INSN-B) (Lima, Peru) were reviewed. We evaluated 83 patients. The median age was 22 months (interquartile range: 14 to 30 months). Of the sample, 71.1% (59) registered previous use of antibiotics. Seventy-two (86.8%) had oligoanuria and 62 (74.6%) had diarrhea. Five cultures were positive (two enterohaemorrhagic Escherichia coli). Forty-nine (59%) required renal replacement therapy. No patient died during hospitalization. At one year of follow-up, seven patients developed post-HUS nephropathy. In conclusion, in INSN-B, the median age was like previous years and there was a higher frequency of oligoanuria, and renal replacement therapy compared to previous reports.